Delivery Order SPE2DB24D3014-SPE2DB25FKTWH
- Not listed
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,064.00, is for the delivery of 4,567,948,312 tablets of 30mg Adderall, a medication used to treat ADHD. The contract has an ultimate completion date of April 18, 2025 and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,949.18 contract is for the supply of Adderall 5 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award has a performance period extending through June 27, 2025 and is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
- This is a $3,067.50 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 100-count bottles of 15mg Adderall tablets, a prescription medication, with a completion date of February 15, 2024. This delivery order is placed under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,798.06, is for the supply of 100-count bottles of 15 mg Adderall tablets. The contract has an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,099.93 contract is for the supply of Adderall 10 mg tablets, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The contract has an ultimate completion date of March 30, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adderall 10 mg tablets, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The delivery order has a ceiling value of $3,614.71 and an ultimate completion date of November 14, 2023. The contract is a firm fixed-price delivery order, with no...
- This is a $8,525.74 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,184,525 units of the prescription medication Adderall 20 mg tablet, with a period of performance through May 9, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,449.98 firm fixed-price delivery order is for the supply of 4,560,869,780 tablets of Adderall 30 mg, a prescription drug used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has a completion date of May 9, 2023 and was awarded on May 8, 2023. AmerisourceBergen holds...
- Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a $2,045.00 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide 4,563,489,863 Adderall 30 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,797.60 firm fixed-price contract is for the delivery of 4,565,159,772 units of Adderall XR 15 mg capsules. This order was issued under a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for providing a comprehensive...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKTWHDelivery Order
This is a $3,594.86 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100-count bottles of Adderall 30 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of July 2, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is part of the company's broader role as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 7/1/25 |